Previous reports suggest that STAT3 inactivation associates with altered cleaved-PARP expression and increased apoptosis.34, 35 Similarly, our research suggests that STAT3 mediated apoptosis by inhibiting the BCL-2 in osteosarcoma cells after Apatinib treatment. The gene discussed is BCL2; the disease is osteosarcoma.